指南与共识神经儿科影像CTMR

印度神经肿瘤学会髓母细胞瘤当代管理共识指南

Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma.
指南 / 共识 · Neurol India · 2017-01-01

印度神经肿瘤学会组建多学科专家组制定髓母细胞瘤国家共识指南,涵盖神经影像术前检查、神经外科管理、神经病理与分子检测、分子时代危险分层、辅助治疗及随访安排,提出最低要求和可选推荐,旨在统一印度诊疗并改善结局。

要点

  • 指南涵盖术前神经影像检查的最低要求和可选推荐。
  • 神经病理报告需整合分子检测用于分子时代危险分层。
  • 辅助治疗和随访方案按危险分层制定。

核心结论

  • 该共识为印度髓母细胞瘤当代治愈性管理提供一般及具体指南和推荐,以统一诊疗、改善疾病相关结局并便于国内机构间比较。

研究设计与样本

  • 印度神经肿瘤学会(ISNO)组建多学科专家组制定国家共识指南,专家组涵盖所有利益相关方。

诊断标准与关键数值

  • 术前检查包括神经影像,制定最低要求和可选推荐。
  • 神经外科管理包括手术原则、技术和并发症。
  • 神经病理报告和分子检测纳入推荐。
  • 分子时代危险分层为推荐内容。
  • 辅助治疗包括放疗和化疗,并制定随访计划。

临床应用与阅片要点

  • 指南推荐用于印度医师和医疗提供者,以统一髓母细胞瘤诊疗。
  • 术前神经影像检查按最低要求执行,可选推荐酌情采用。
  • 神经病理报告应包含分子检测以支持危险分层。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The high success rate in the management medulloblastoma achieved in the western world is not exactly mirrored in developing countries including India. Socio-demographic differences, health-care disparity, and lack in uniformity of care with resultant widespread variations in the clinical practice are some of the reasons that may partly explain this difference in outcomes. Patients with medulloblastoma require a multi-disciplinary team approach involving but not limited to neuro-radiology, neurosurgery; neuropathology, molecular biology, radiation oncology, pediatric medical oncology and rehabilitative services for optimizing outcomes.

METHODS: The Indian Society of Neuro-Oncology (ISNO) constituted an expert multi-disciplinary panel with adequate representation from all stakeholders to prepare national consensus guidelines for the contemporary management of medulloblastoma.

RESULTS: Minimum desirable, as well as preferable though optional recommendations (as appropriate), were developed and adopted for the pre-surgical work-up including neuroimaging; neurosurgical management including surgical principles, techniques, and complications; neuropathology reporting and molecular testing; contemporary risk-stratification in the molecular era; appropriate adjuvant therapy (radiotherapy and chemotherapy); and follow-up schedule in medulloblastoma.

CONCLUSIONS: The current document represents a broad consensus reached amongst various stakeholders within the neuro-oncology community involved in the contemporary curative-intent management of children with medulloblastoma. It provides both general as well as specific guidelines and recommendations to be adopted by physicians and health care providers across India to achieve uniformity of care, improve disease-related outcomes, and compare results between institutions within the country.

来源:Neurol India,查看原文。版权归原作者所有。

引用

  1. Gupta T, Sarkar C, Rajshekhar V, et al. Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma. Neurol India. 2017. PMID: 28290395. doi:10.4103/0028-3886.201841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。